Greater Cannabis Company (GCAN) Change in Accured Expenses (2016 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Change in Accured Expenses of $30000.0 in Q1 2026, up 138.28% quarter-over-quarter from -$78373.0 in Q4 2025, and little changed on a YoY basis from $30000.0 in Q1 2025.
Greater Cannabis Company (GCAN) Change in Accured Expenses (2016 - 2026) Analysis & Trends
Greater Cannabis Company's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $30000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses changed 0.0% year-over-year to $30000.0; the TTM figure through Mar 2026 stood at $1627.0 (down 96.55% YoY), while the FY2025 annual figure was $1627.0, down 92.85% from the prior year.
- Change in Accured Expenses was $30000.0 for Q1 2026 at Greater Cannabis Company, up from -$78373.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $30000.0 in Q1 2023 to a low of -$78373.0 in Q4 2025.
- Historically, Change in Accured Expenses has averaged $5401.2 across 5 years, with a median of $6913.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses jumped 931.79% in 2022, then tumbled 6602.02% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at $5133.0 in 2022, then slumped by 44.79% to $2834.0 in 2023, then surged by 101.94% to $5723.0 in 2024, then tumbled by 1469.44% to -$78373.0 in 2025, then soared by 138.28% to $30000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $30000.0 (Q1 2026), -$78373.0 (Q4 2025), and $30000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 23.00 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 10.02 Mn |
| 10 | Greater Cannabis Company | - | - | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | -78,373.00 |
| Dec 31, 2025 | -78,373.00 |
| Sep 30, 2025 | 30,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 5,723.00 |
| Dec 31, 2024 | 5,723.00 |
| Sep 30, 2024 | 27,042.00 |
| Sep 30, 2024 | 27,042.00 |
| Jun 30, 2024 | -15,660.00 |
| Jun 30, 2024 | -15,660.00 |
| Mar 31, 2024 | 5,660.00 |
| Mar 31, 2024 | 5,660.00 |
| Dec 31, 2023 | 2,834.00 |
| Dec 31, 2023 | 2,834.00 |